Comment on Abd El Aziz et al., A meta-analysis comparing clinical effects of short- or long-acting GLP-1 receptor agonists versus insulin treatment from head-to-head studies in type 2 diabetic patients.

Autor: Home P; Institute of Cellular Medicine - Diabetes, The Medical School, Newcastle University, Newcastle upon Tyne, UK.
Jazyk: angličtina
Zdroj: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2017 Feb; Vol. 19 (2), pp. 304-305.
DOI: 10.1111/dom.12842
Databáze: MEDLINE